10-Q Filing

Astrana Health, Inc. CIK: 1083446 Q3 2019

Filing Information

Form Type	10-Q
Accession Number	`0001628280-19-013826`
Period End Date	20190930
Filing Date	20191108
Fiscal Year	2019
Fiscal Period	Q3
XBRL Instance	ameh-20190930.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 107 Income Statement 88 Cash Flow Statement 125 Stockholders Equity 44

Balance Sheet 107 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$119.78M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$230.30M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$106.89M	USD	Point-in-time
Restricted cash	`RestrictedCashCurrent`	$20.15K	USD	Point-in-time
Restricted cash	`RestrictedCashCurrent`	-	USD	Point-in-time
Common Stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Investment in marketable securities	`MarketableSecuritiesCurrent`	$1.15M	USD	Point-in-time
Investment in marketable securities	`MarketableSecuritiesCurrent`	$1.13M	USD	Point-in-time
Common Stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Receivables, net	`AccountsReceivableNetCurrent`	$7.13M	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Receivables, net	`AccountsReceivableNetCurrent`	$19.73M	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	34.82M	shares	Point-in-time
Receivables, net related parties	`AccountsReceivableRelatedPartiesCurrent`	$37.71M	USD	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	34.58M	shares	Point-in-time
Receivables, net related parties	`AccountsReceivableRelatedPartiesCurrent`	$49.33M	USD	Point-in-time
Other receivables	`OtherReceivablesNetCurrent`	$15.53M	USD	Point-in-time
Other receivables	`OtherReceivablesNetCurrent`	$1.00M	USD	Point-in-time
Treasury shares (in shares)	`TreasuryStockCommonShares`	16.96M	shares	Point-in-time
Treasury shares (in shares)	`TreasuryStockCommonShares`	1.85M	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$10.50M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$7.39M	USD	Point-in-time
Loans receivable - related parties	`NotesReceivableRelatedPartiesCurrent`	-	USD	Point-in-time
Loans receivable - related parties	`NotesReceivableRelatedPartiesCurrent`	$6.42M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$172.86M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$321.36M	USD	Point-in-time
Land, property and equipment, net	`PropertyPlantAndEquipmentNet`	$12.43M	USD	Point-in-time
Land, property and equipment, net	`PropertyPlantAndEquipmentNet`	$12.72M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$114.17M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$86.88M	USD	Point-in-time
Goodwill	`Goodwill`	$237.13M	USD	Point-in-time
Goodwill	`Goodwill`	$185.81M	USD	Point-in-time
Loans receivable related parties, net of current portion	`DueFromRelatedPartiesNoncurrent`	$12.50M	USD	Point-in-time
Loans receivable related parties, net of current portion	`DueFromRelatedPartiesNoncurrent`	$17.50M	USD	Point-in-time
Investment in other entities equity method	`EquityMethodInvestments`	$34.88M	USD	Point-in-time
Investment in other entities equity method	`EquityMethodInvestments`	$35.84M	USD	Point-in-time
Investment in a privately held entity that does not report net asset value per share	`InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue`	$405.00K	USD	Point-in-time
Investment in a privately held entity that does not report net asset value per share	`InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue`	$896.00K	USD	Point-in-time
Restricted cash	`RestrictedCashNoncurrent`	$746.10K	USD	Point-in-time
Restricted cash	`RestrictedCashNoncurrent`	$745.47K	USD	Point-in-time
Right-of-use assets	`OperatingLeaseRightOfUseAsset`	$9.00M	USD	Point-in-time
Right-of-use assets	`OperatingLeaseRightOfUseAsset`	$13.54M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$1.63M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$1.21M	USD	Point-in-time
Total noncurrent assets	`AssetsNoncurrent`	$340.14M	USD	Point-in-time
Total noncurrent assets	`AssetsNoncurrent`	$428.88M	USD	Point-in-time
Total assets	`Assets`	$513.00M	USD	Point-in-time
Total assets	`Assets`	$750.24M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$25.08M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$35.54M	USD	Point-in-time
Fiduciary accounts payable	`FiduciaryAccountsPayableCurrent`	$1.54M	USD	Point-in-time
Fiduciary accounts payable	`FiduciaryAccountsPayableCurrent`	$1.73M	USD	Point-in-time
Medical liabilities	`MedicalLiabilitiesCurrent`	$53.82M	USD	Point-in-time
Medical liabilities	`MedicalLiabilitiesCurrent`	$33.64M	USD	Point-in-time
Medical liabilities	`MedicalLiabilitiesCurrent`	$63.97M	USD	Point-in-time
Income taxes payable	`AccruedIncomeTaxesCurrent`	$11.62M	USD	Point-in-time
Income taxes payable	`AccruedIncomeTaxesCurrent`	$1.39M	USD	Point-in-time
Bank loan	`ShortTermBankLoansAndNotesPayable`	-	USD	Point-in-time
Bank loan	`ShortTermBankLoansAndNotesPayable`	$40.26K	USD	Point-in-time
Dividend payable	`DividendsPayableCurrent`	$271.28K	USD	Point-in-time
Finance lease liabilities	`FinanceLeaseLiabilityCurrent`	$101.74K	USD	Point-in-time
Finance lease liabilities	`FinanceLeaseLiabilityCurrent`	$101.74K	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$2.84M	USD	Point-in-time
Current portion of long term debt	`LongTermDebtCurrent`	$9.50M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$105.20M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$72.02M	USD	Point-in-time
Lines of credit related party	`DueToRelatedPartiesNoncurrent`	$13.00M	USD	Point-in-time
Lines of credit related party	`DueToRelatedPartiesNoncurrent`	-	USD	Point-in-time
Deferred tax liability	`DeferredTaxLiabilities`	$19.62M	USD	Point-in-time
Deferred tax liability	`DeferredTaxLiabilities`	$30.20M	USD	Point-in-time
Liability for unissued equity shares	`LiabilityForUnissuedEquitySharesNoncurrent`	$1.19M	USD	Point-in-time
Liability for unissued equity shares	`LiabilityForUnissuedEquitySharesNoncurrent`	$1.19M	USD	Point-in-time
Finance lease liabilities	`FinanceLeaseLiabilityNoncurrent`	$517.26K	USD	Point-in-time
Finance lease liabilities	`FinanceLeaseLiabilityNoncurrent`	$441.24K	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$10.67M	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	-	USD	Point-in-time
Long-term debt, net of current portion and deferred financing costs	`LongTermDebtNoncurrent`	$234.15M	USD	Point-in-time
Long-term debt, net of current portion and deferred financing costs	`LongTermDebtNoncurrent`	-	USD	Point-in-time
Total noncurrent liabilities	`LiabilitiesNoncurrent`	$34.32M	USD	Point-in-time
Total noncurrent liabilities	`LiabilitiesNoncurrent`	$276.65M	USD	Point-in-time
Total liabilities	`Liabilities`	$381.84M	USD	Point-in-time
Total liabilities	`Liabilities`	$106.34M	USD	Point-in-time
Commitments and Contingencies (Note 11)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and Contingencies (Note 11)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Noncontrolling interest in Allied Physicians of California, a Professional Medical Corporation (APC)	`TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests`	$225.12M	USD	Point-in-time
Noncontrolling interest in Allied Physicians of California, a Professional Medical Corporation (APC)	`TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests`	$176.23M	USD	Point-in-time
Common stock, $0.001 par value; 100,000,000 shares authorized, 34,822,933 and 34,578,040 shares outstanding, excluding 16,959,069 and 1,850,603 treasury shares, at September 30, 2019 and December 31, 2018, respectively	`CommonStockValue`	$34.82K	USD	Point-in-time
Common stock, $0.001 par value; 100,000,000 shares authorized, 34,822,933 and 34,578,040 shares outstanding, excluding 16,959,069 and 1,850,603 treasury shares, at September 30, 2019 and December 31, 2018, respectively	`CommonStockValue`	$34.58K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$162.72M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$165.52M	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$25.18M	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$17.79M	USD	Point-in-time
Retained earnings	`StockholdersEquity`	$190.73M	USD	Point-in-time
Retained earnings	`StockholdersEquity`	$180.55M	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$1.44M	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$998.32K	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$170.49M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$174.82M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$182.38M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$181.54M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$185.13M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$186.09M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$192.17M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$164.18M	USD	Point-in-time
Total liabilities, mezzanine equity and stockholders equity	`LiabilitiesAndStockholdersEquity`	$513.00M	USD	Point-in-time
Total liabilities, mezzanine equity and stockholders equity	`LiabilitiesAndStockholdersEquity`	$750.24M	USD	Point-in-time

Income Statement 88 line items

Line Item	Tag	Value	Unit	Period
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$156.06M	USD	1 Quarter
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$166.73M	USD	1 Quarter
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$413.32M	USD	3 Qtrs
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$381.87M	USD	3 Qtrs
Cost of services	`CostOfGoodsAndServicesSold`	$315.93M	USD	3 Qtrs
Cost of services	`CostOfGoodsAndServicesSold`	$131.13M	USD	1 Quarter
Cost of services	`CostOfGoodsAndServicesSold`	$280.59M	USD	3 Qtrs
Cost of services	`CostOfGoodsAndServicesSold`	$96.27M	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$9.04M	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$7.95M	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$30.03M	USD	3 Qtrs
General and administrative expenses	`GeneralAndAdministrativeExpense`	$31.48M	USD	3 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$4.84M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$13.79M	USD	3 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$4.92M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$14.82M	USD	3 Qtrs
Provision for doubtful accounts	`AllowanceForDoubtfulAccountsReceivableRecoveries`	-	USD	1 Quarter
Provision for doubtful accounts	`AllowanceForDoubtfulAccountsReceivableRecoveries`	$1.36M	USD	3 Qtrs
Provision for doubtful accounts	`AllowanceForDoubtfulAccountsReceivableRecoveries`	-	USD	3 Qtrs
Provision for doubtful accounts	`AllowanceForDoubtfulAccountsReceivableRecoveries`	-	USD	1 Quarter
Impairment of intangibles	`ImpairmentOfIntangibleAssetsExcludingGoodwill`	$1.99M	USD	1 Quarter
Impairment of intangibles	`ImpairmentOfIntangibleAssetsExcludingGoodwill`	-	USD	3 Qtrs
Impairment of intangibles	`ImpairmentOfIntangibleAssetsExcludingGoodwill`	$1.99M	USD	3 Qtrs
Impairment of intangibles	`ImpairmentOfIntangibleAssetsExcludingGoodwill`	-	USD	1 Quarter
Total expenses	`OperatingExpenses`	$326.89M	USD	3 Qtrs
Total expenses	`OperatingExpenses`	$110.15M	USD	1 Quarter
Total expenses	`OperatingExpenses`	$145.99M	USD	1 Quarter
Total expenses	`OperatingExpenses`	$360.38M	USD	3 Qtrs
Income from operations	`OperatingIncomeLoss`	$86.43M	USD	3 Qtrs
Income from operations	`OperatingIncomeLoss`	$56.58M	USD	1 Quarter
Income from operations	`OperatingIncomeLoss`	$21.49M	USD	3 Qtrs
Income from operations	`OperatingIncomeLoss`	$10.07M	USD	1 Quarter
Income (loss) from equity method investments	`IncomeLossFromEquityMethodInvestments`	$2.05M	USD	1 Quarter
Income (loss) from equity method investments	`IncomeLossFromEquityMethodInvestments`	$-2.57M	USD	3 Qtrs
Income (loss) from equity method investments	`IncomeLossFromEquityMethodInvestments`	$1.16M	USD	3 Qtrs
Income (loss) from equity method investments	`IncomeLossFromEquityMethodInvestments`	$-4.22M	USD	1 Quarter
Interest expense	`InterestExpense`	$374.00K	USD	3 Qtrs
Interest expense	`InterestExpense`	$827.90K	USD	1 Quarter
Interest expense	`InterestExpense`	$1.35M	USD	3 Qtrs
Interest expense	`InterestExpense`	$178.32K	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$508.86K	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$1.31M	USD	3 Qtrs
Interest income	`InvestmentIncomeInterest`	$1.18M	USD	3 Qtrs
Interest income	`InvestmentIncomeInterest`	$418.45K	USD	1 Quarter
Other income	`OtherNonoperatingIncomeExpense`	$2.83M	USD	3 Qtrs
Other income	`OtherNonoperatingIncomeExpense`	$2.62M	USD	1 Quarter
Other income	`OtherNonoperatingIncomeExpense`	$884.95K	USD	3 Qtrs
Other income	`OtherNonoperatingIncomeExpense`	$609.20K	USD	1 Quarter
Total other income (expense), net	`NonoperatingIncomeExpense`	$4.36M	USD	1 Quarter
Total other income (expense), net	`NonoperatingIncomeExpense`	$3.95M	USD	3 Qtrs
Total other income (expense), net	`NonoperatingIncomeExpense`	$-881.28K	USD	3 Qtrs
Total other income (expense), net	`NonoperatingIncomeExpense`	$-3.37M	USD	1 Quarter
Income before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$14.42M	USD	1 Quarter
Income before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$85.55M	USD	3 Qtrs
Income before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$25.44M	USD	3 Qtrs
Income before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$53.21M	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	$23.34M	USD	3 Qtrs
Provision for income taxes	`IncomeTaxExpenseBenefit`	$6.48M	USD	3 Qtrs
Provision for income taxes	`IncomeTaxExpenseBenefit`	$14.59M	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	$3.68M	USD	1 Quarter
Net income	`ProfitLoss`	$38.63M	USD	1 Quarter
Net income	`ProfitLoss`	$62.21M	USD	3 Qtrs
Net income	`ProfitLoss`	$10.74M	USD	1 Quarter
Net income	`ProfitLoss`	$18.95M	USD	3 Qtrs
Net income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$11.56M	USD	3 Qtrs
Net income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$7.03M	USD	1 Quarter
Net income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$48.28M	USD	3 Qtrs
Net income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$29.52M	USD	1 Quarter
Net income attributable to Apollo Medical Holdings, Inc.	`NetIncomeLoss`	$3.70M	USD	1 Quarter
Net income attributable to Apollo Medical Holdings, Inc.	`NetIncomeLoss`	$13.93M	USD	3 Qtrs
Net income attributable to Apollo Medical Holdings, Inc.	`NetIncomeLoss`	$7.39M	USD	3 Qtrs
Net income attributable to Apollo Medical Holdings, Inc.	`NetIncomeLoss`	$9.11M	USD	1 Quarter
Earnings per share basic (in dollars per share)	`EarningsPerShareBasic`	$0.11	USD	1 Quarter
Earnings per share basic (in dollars per share)	`EarningsPerShareBasic`	$0.43	USD	3 Qtrs
Earnings per share basic (in dollars per share)	`EarningsPerShareBasic`	$0.21	USD	3 Qtrs
Earnings per share basic (in dollars per share)	`EarningsPerShareBasic`	$0.28	USD	1 Quarter
Earnings per share diluted (in dollars per share)	`EarningsPerShareDiluted`	$0.20	USD	3 Qtrs
Earnings per share diluted (in dollars per share)	`EarningsPerShareDiluted`	$0.24	USD	1 Quarter
Earnings per share diluted (in dollars per share)	`EarningsPerShareDiluted`	$0.10	USD	1 Quarter
Earnings per share diluted (in dollars per share)	`EarningsPerShareDiluted`	$0.37	USD	3 Qtrs
Weighted average shares of common stock outstanding basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	34.56M	shares	3 Qtrs
Weighted average shares of common stock outstanding basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	32.92M	shares	1 Quarter
Weighted average shares of common stock outstanding basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	32.67M	shares	3 Qtrs
Weighted average shares of common stock outstanding basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	34.64M	shares	1 Quarter
Weighted average shares of common stock outstanding diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	38.39M	shares	1 Quarter
Weighted average shares of common stock outstanding diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	38.01M	shares	3 Qtrs
Weighted average shares of common stock outstanding diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	37.82M	shares	3 Qtrs
Weighted average shares of common stock outstanding diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	37.79M	shares	1 Quarter

Cash Flow Statement 125 line items

Line Item	Tag	Value	Unit	Period
Net income	`ProfitLoss`	$38.63M	USD	1 Quarter
Net income	`ProfitLoss`	$62.21M	USD	3 Qtrs
Net income	`ProfitLoss`	$10.74M	USD	1 Quarter
Net income	`ProfitLoss`	$18.95M	USD	3 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$4.84M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$13.79M	USD	3 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$4.92M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$14.82M	USD	3 Qtrs
Impairment of intangible	`ImpairmentOfIntangibleAssetsExcludingGoodwill`	$1.99M	USD	1 Quarter
Impairment of intangible	`ImpairmentOfIntangibleAssetsExcludingGoodwill`	-	USD	3 Qtrs
Impairment of intangible	`ImpairmentOfIntangibleAssetsExcludingGoodwill`	$1.99M	USD	3 Qtrs
Impairment of intangible	`ImpairmentOfIntangibleAssetsExcludingGoodwill`	-	USD	1 Quarter
Loss on disposal of property and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	$-41.78K	USD	3 Qtrs
Loss on disposal of property and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	-	USD	3 Qtrs
Provision for doubtful accounts	`AllowanceForDoubtfulAccountsReceivableRecoveries`	-	USD	1 Quarter
Provision for doubtful accounts	`AllowanceForDoubtfulAccountsReceivableRecoveries`	$1.36M	USD	3 Qtrs
Provision for doubtful accounts	`AllowanceForDoubtfulAccountsReceivableRecoveries`	-	USD	3 Qtrs
Provision for doubtful accounts	`AllowanceForDoubtfulAccountsReceivableRecoveries`	-	USD	1 Quarter
Share-based compensation	`AllocatedShareBasedCompensationExpense`	$1.01M	USD	3 Qtrs
Share-based compensation	`AllocatedShareBasedCompensationExpense`	$1.24M	USD	3 Qtrs
Gain on loan assumption	`GainLossOnAssumptionOfLoan`	-	USD	3 Qtrs
Gain on loan assumption	`GainLossOnAssumptionOfLoan`	$2.25M	USD	3 Qtrs
Unrealized (gain) loss from investment in equity securities	`UnrealizedGainLossOnInvestments`	$6.28K	USD	3 Qtrs
Unrealized (gain) loss from investment in equity securities	`UnrealizedGainLossOnInvestments`	$-10.22K	USD	3 Qtrs
(Income) loss from equity method investments	`IncomeLossFromEquityMethodInvestments`	$2.05M	USD	1 Quarter
(Income) loss from equity method investments	`IncomeLossFromEquityMethodInvestments`	$-2.57M	USD	3 Qtrs
(Income) loss from equity method investments	`IncomeLossFromEquityMethodInvestments`	$1.16M	USD	3 Qtrs
(Income) loss from equity method investments	`IncomeLossFromEquityMethodInvestments`	$-4.22M	USD	1 Quarter
Deferred tax	`DeferredIncomeTaxExpenseBenefit`	$-185.70K	USD	3 Qtrs
Deferred tax	`DeferredIncomeTaxExpenseBenefit`	$7.14M	USD	3 Qtrs
Receivable, net	`IncreaseDecreaseInAccountsReceivable`	$-1.91M	USD	3 Qtrs
Receivable, net	`IncreaseDecreaseInAccountsReceivable`	$-4.48M	USD	3 Qtrs
Receivable, net related parties	`IncreaseDecreaseInDueFromRelatedParties`	$-5.86M	USD	3 Qtrs
Receivable, net related parties	`IncreaseDecreaseInDueFromRelatedParties`	$43.36M	USD	3 Qtrs
Other receivables	`IncreaseDecreaseInOtherReceivables`	-	USD	3 Qtrs
Other receivables	`IncreaseDecreaseInOtherReceivables`	$13.72M	USD	3 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets`	$2.91M	USD	3 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets`	$80.62K	USD	3 Qtrs
Right-of-use assets	`IncreaseDecreaseInOperatingLeaseAssets`	-	USD	3 Qtrs
Right-of-use assets	`IncreaseDecreaseInOperatingLeaseAssets`	$1.88M	USD	3 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$26.93K	USD	3 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$524.69K	USD	3 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$4.87M	USD	3 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$31.70M	USD	3 Qtrs
Dividends payable	`IncreaseDecreaseInDividendsPayable`	-	USD	3 Qtrs
Dividends payable	`IncreaseDecreaseInDividendsPayable`	-	USD	3 Qtrs
Incentives payable	`IncreaseDecreaseInIncentivesPayable`	$-16.50M	USD	3 Qtrs
Incentives payable	`IncreaseDecreaseInIncentivesPayable`	-	USD	3 Qtrs
Fiduciary accounts payable	`IncreaseDecreaseInOtherAccountsPayable`	-	USD	3 Qtrs
Fiduciary accounts payable	`IncreaseDecreaseInOtherAccountsPayable`	$195.54K	USD	3 Qtrs
Medical liabilities	`IncreaseDecreaseInMedicalLiabilities`	$-30.47M	USD	3 Qtrs
Medical liabilities	`IncreaseDecreaseInMedicalLiabilities`	$-6.23M	USD	3 Qtrs
Income taxes payable	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$-10.23M	USD	3 Qtrs
Income taxes payable	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$-1.91M	USD	3 Qtrs
Operating lease liabilities	`IncreaseDecreaseInOtherOperatingLeaseLiabilities`	-	USD	3 Qtrs
Operating lease liabilities	`IncreaseDecreaseInOtherOperatingLeaseLiabilities`	$-1.79M	USD	3 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$10.08M	USD	3 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$31.86M	USD	3 Qtrs
Payments for business acquisitions, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	-	USD	3 Qtrs
Payments for business acquisitions, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$49.40M	USD	3 Qtrs
Advances on loans receivable	`PaymentsToFundLongtermLoansToRelatedParties`	$2.50M	USD	3 Qtrs
Advances on loans receivable	`PaymentsToFundLongtermLoansToRelatedParties`	$7.42M	USD	3 Qtrs
Purchases of marketable securities	`PaymentsToAcquireMarketableSecurities`	$21.09K	USD	3 Qtrs
Purchases of marketable securities	`PaymentsToAcquireMarketableSecurities`	$9.01K	USD	3 Qtrs
Purchases of investment - equity method	`PaymentsToAcquireEquityMethodInvestments`	$2.95M	USD	3 Qtrs
Purchases of investment - equity method	`PaymentsToAcquireEquityMethodInvestments`	$16.67M	USD	3 Qtrs
Purchases of a privately held entity that does not report net asset value per share	`PaymentOfInvestmentPrivatelyHeldEntityDoesNotReportToNAVPerShare`	-	USD	3 Qtrs
Purchases of a privately held entity that does not report net asset value per share	`PaymentOfInvestmentPrivatelyHeldEntityDoesNotReportToNAVPerShare`	$405.00K	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$867.73K	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$806.59K	USD	3 Qtrs
Dividend received	`ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital`	$207.41K	USD	3 Qtrs
Dividend received	`ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital`	$240.00K	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-60.36M	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-20.25M	USD	3 Qtrs
Repayment of bank loan and lines of credit	`RepaymentsOfRelatedPartyDebt`	$52.64M	USD	3 Qtrs
Repayment of bank loan and lines of credit	`RepaymentsOfRelatedPartyDebt`	$375.49K	USD	3 Qtrs
Dividends paid	`PaymentsOfDividends`	$16.73M	USD	3 Qtrs
Dividends paid	`PaymentsOfDividends`	$60.67M	USD	3 Qtrs
Change in noncontrolling interest capital	`ProceedsFromPaymentsToMinorityShareholders`	-	USD	3 Qtrs
Change in noncontrolling interest capital	`ProceedsFromPaymentsToMinorityShareholders`	$27.30K	USD	3 Qtrs
Payment of capital lease obligations	`RepaymentsOfDebtAndCapitalLeaseObligations`	$73.78K	USD	3 Qtrs
Payment of capital lease obligations	`RepaymentsOfDebtAndCapitalLeaseObligations`	$76.02K	USD	3 Qtrs
Proceeds from the exercise of stock options and warrants	`ProceedsFromWarrantExercises`	$3.57M	USD	3 Qtrs
Proceeds from the exercise of stock options and warrants	`ProceedsFromWarrantExercises`	$2.40M	USD	3 Qtrs
Repurchase of shares	`PaymentsForRepurchaseOfCommonStock`	$40.00K	USD	3 Qtrs
Repurchase of shares	`PaymentsForRepurchaseOfCommonStock`	-	USD	3 Qtrs
Borrowings on line of credit and long-term debt	`ProceedsFromRelatedPartyDebt`	$8.00M	USD	3 Qtrs
Borrowings on line of credit and long-term debt	`ProceedsFromRelatedPartyDebt`	$289.60M	USD	3 Qtrs
Proceeds from common stock offering	`ProceedsFromIssuanceOfCommonStock`	$755.00K	USD	3 Qtrs
Proceeds from common stock offering	`ProceedsFromIssuanceOfCommonStock`	$200.00K	USD	3 Qtrs
Cost of debt and equity issuance costs	`PaymentOfFinancingAndStockIssuanceCosts`	-	USD	3 Qtrs
Cost of debt and equity issuance costs	`PaymentOfFinancingAndStockIssuanceCosts`	$5.62M	USD	3 Qtrs
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$173.71M	USD	3 Qtrs
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-5.37M	USD	3 Qtrs
Net increase in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$123.43M	USD	3 Qtrs
Net increase in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$6.24M	USD	3 Qtrs
Cash, cash equivalents and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$231.06M	USD	Point-in-time
Cash, cash equivalents and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$107.64M	USD	Point-in-time
Cash, cash equivalents and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$118.50M	USD	Point-in-time
Cash, cash equivalents and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$124.74M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$231.06M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$107.64M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$118.50M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$124.74M	USD	Point-in-time
Cash paid for income taxes	`IncomeTaxesPaid`	$18.03M	USD	3 Qtrs
Cash paid for income taxes	`IncomeTaxesPaid`	$17.90M	USD	3 Qtrs
Cash paid for interest	`InterestPaidNet`	$999.58K	USD	3 Qtrs
Cash paid for interest	`InterestPaidNet`	$287.33K	USD	3 Qtrs
Cashless exercise of stock options	`CashlessExerciseOfStockOptions`	-	USD	3 Qtrs
Cashless exercise of stock options	`CashlessExerciseOfStockOptions`	$47.00	USD	3 Qtrs
Deferred tax liability adjustment to goodwill	`DeferredTaxLiabilityAdjustedToGoodwill`	$1.11M	USD	3 Qtrs
Deferred tax liability adjustment to goodwill	`DeferredTaxLiabilityAdjustedToGoodwill`	$11.54M	USD	3 Qtrs
APC stock issued in exchange for AMG	`StockIssued1`	$414.25K	USD	3 Qtrs
APC stock issued in exchange for AMG	`StockIssued1`	-	USD	3 Qtrs
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$119.78M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$230.30M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$106.89M	USD	Point-in-time
Restricted cash short-term - distributions to former NMM shareholders	`RestrictedCashEquivalentsCurrent`	$4.22M	USD	Point-in-time
Restricted cash short-term - distributions to former NMM shareholders	`RestrictedCashEquivalentsCurrent`	$20.15K	USD	Point-in-time
Restricted cash letters of credit	`RestrictedCashEquivalentsNoncurrent`	$745.41K	USD	Point-in-time
Restricted cash letters of credit	`RestrictedCashEquivalentsNoncurrent`	$746.10K	USD	Point-in-time
Total cash, cash equivalents, and restricted cash shown in the statement of cash flows	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$231.06M	USD	Point-in-time
Total cash, cash equivalents, and restricted cash shown in the statement of cash flows	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$107.64M	USD	Point-in-time
Total cash, cash equivalents, and restricted cash shown in the statement of cash flows	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$118.50M	USD	Point-in-time
Total cash, cash equivalents, and restricted cash shown in the statement of cash flows	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$124.74M	USD	Point-in-time

Stockholders Equity 44 line items

Line Item	Tag	Value	Unit	Period
Equity, beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$170.49M	USD	Point-in-time
Equity, beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$174.82M	USD	Point-in-time
Equity, beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$182.38M	USD	Point-in-time
Equity, beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$181.54M	USD	Point-in-time
Equity, beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$185.13M	USD	Point-in-time
Equity, beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$186.09M	USD	Point-in-time
Equity, beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$192.17M	USD	Point-in-time
Equity, beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$164.18M	USD	Point-in-time
Net income	`NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity`	$4.45M	USD	1 Quarter
Net income	`NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity`	$9.59M	USD	1 Quarter
Net income	`NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity`	$3.77M	USD	1 Quarter
Net income	`NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity`	$2.75M	USD	1 Quarter
Net income	`NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity`	$549.89K	USD	1 Quarter
Net income	`NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity`	$3.01M	USD	1 Quarter
Purchase of treasury shares	`TreasuryStockValueAcquiredParValueMethod`	-	USD	1 Quarter
Purchase price adjustment from merger	`AdjustmentsToAdditionalPaidInCapitalMergerPurchasePriceAdjustment`	$868.00K	USD	1 Quarter
Shares issued for exercise of options and warrants	`StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants`	$1.50M	USD	1 Quarter
Shares issued for exercise of options and warrants	`StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants`	$758.13K	USD	1 Quarter
Shares issued for exercise of options and warrants	`StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants`	$139.97K	USD	1 Quarter
Shares issued for exercise of options and warrants	`StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants`	$1.92M	USD	1 Quarter
Shares issued for exercise of options and warrants	`StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants`	$423.55K	USD	1 Quarter
Shares issued for exercise of options and warrants	`StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants`	$1.23M	USD	1 Quarter
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$631.56K	USD	1 Quarter
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$142.75K	USD	1 Quarter
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	-	USD	1 Quarter
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	-	USD	1 Quarter
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$128.00K	USD	1 Quarter
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$128.00K	USD	1 Quarter
Acquisition of additional shares in consolidated equity	`NoncontrollingInterestIncreaseFromBusinessCombination`	$-200.00	USD	1 Quarter
Purchase of treasury shares	`TreasuryStockValueAcquiredCostMethod`	$-432.11K	USD	1 Quarter
Noncontrolling interest capital charge	`NoncontrollingInterestIncreaseFromCapitalCharge`	$27.50K	USD	1 Quarter
Dividends	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	-	USD	1 Quarter
Dividends	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	-	USD	1 Quarter
Dividends	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	$941.59K	USD	1 Quarter
Dividends	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	$942.00K	USD	1 Quarter
Dividends	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	-	USD	1 Quarter
Equity, ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$170.49M	USD	Point-in-time
Equity, ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$174.82M	USD	Point-in-time
Equity, ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$182.38M	USD	Point-in-time
Equity, ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$181.54M	USD	Point-in-time
Equity, ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$185.13M	USD	Point-in-time
Equity, ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$186.09M	USD	Point-in-time
Equity, ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$192.17M	USD	Point-in-time
Equity, ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$164.18M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.